Mark Lebwohl, MD
Professor and Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology
Dean for Clinical Therapeutics at the Icahn School of Medicine, Mount Sinai
New York, NY
Areas of Expertise
Disclosure
Grant/Research Support: Abbvie, Arcutis, Avotres, Boehringer Ingelheim, Cara therapeutics, Clexio, Dermavant Sciences, Eli Lilly, Incyte, Inozyme, Johnson & Johnson, Pfizer, Sanofi-Regeneron, and UCB, Inc.
Consultant: Aikium, Almirall, AltruBio Inc., Amgen, Apogee Therapeutics, Arcutis, Inc., AstraZeneca, Atomwise, Avotres Therapeutics, Boehringer-Ingelheim, Bristol-Myers Squibb, Castle Biosciences, Celltrion, Corevitas, Dermavant Sciences, Evommune, Inc., Facilitation of International Dermatology Education, Forte biosciences, Foundation for Research and Education in Dermatology, Galderma, Genentech, Goodrx-Mayne, Incyte, LEO Pharma, Meiji Seika Pharma, Mindera, Mirum Pharmaceuticals, Oruka, Pfizer, Revolo, Sanofi-Regeneron, Seanergy, Strata, Sun Pharma, Takeda, Trevi, and Verrica.